US-China tension may help with China's innovation

By Wang Fangqing

The year-long US-China tension demands a fairer Chinese market access for global companies, and it might benefit China’s drug innovation, said speakers at the annual China Healthcare Investment Conference (CHIC) event held in Shanghai on March 27.

Building a solid intellectual property protection system is one major requirement by the US government, which tries to protect American companies’ patents. Such a system, however, is also highly beneficial to Chinese research pharmas, saidRandall Rader, former US Federal Circuit Judge and a patent law expert who now is a professor in China’s Tsinghua University.